| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/31/1997 | WO1997026790A1 APOPTOSIS INDUCED BY SHIGELLA IpaB |
| 07/31/1997 | WO1997019856A3 Plate-shaped holder housing for daily use and/or consumer articles |
| 07/31/1997 | WO1997018322A3 Method of quantifying tumour cells in a body fluid and a suitable test kit |
| 07/31/1997 | DE19602863A1 Agent for treating cancer and other diseases involving hyper-proliferation of cells |
| 07/31/1997 | DE19545351C1 Eukaryotische Zellen mit Hybridrezeptor und dadurch steuerbarem Genkonstrukt, Verfahren zu deren Herstellung und Verwendung dieser Zellen in der Gentherapie Eukaryotic cells with hybrid receptor and thereby controllable gene construct, to processes for their preparation and use of these cells for gene therapy |
| 07/31/1997 | CA2245003A1 Cloned plant p-hydroxyphenyl pyruvic acid dioxygenase |
| 07/31/1997 | CA2245002A1 Malaria vaccine based upon the addition of a msa1 peptide |
| 07/31/1997 | CA2244700A1 Method for analyzing repeat nucleic acid sequences |
| 07/31/1997 | CA2244693A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 07/31/1997 | CA2244412A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | CA2244373A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | CA2244372A1 Methods for identifying inhibitors of rna viruses |
| 07/31/1997 | CA2244222A1 Methods for screening for transdominant effector peptides and rna molecules |
| 07/31/1997 | CA2244147A1 Decorin binding protein compositions and methods of use |
| 07/31/1997 | CA2243989A1 Methods and compositions for detecting binding of ligand pair using non-fluorescent label |
| 07/31/1997 | CA2243969A1 Plant tissue/stage specific promoters for regulated expression of transgenes in plants |
| 07/31/1997 | CA2243850A1 Raspberry promoters for expression of transgenes in plants |
| 07/31/1997 | CA2243560A1 Methods and compositions for determining the sequence of nucleic acid molecules |
| 07/31/1997 | CA2243533A1 Ligand directed enzyme prodrug therapy |
| 07/31/1997 | CA2243529A1 Retroviral vector and its use in gene therapy |
| 07/31/1997 | CA2242960A1 Inhibitors of cell-cycle progression, and uses related thereto |
| 07/31/1997 | CA2242417A1 Novel administration of thrombopoietin |
| 07/31/1997 | CA2242200A1 Toxoplasma gondii antigen tg20 |
| 07/31/1997 | CA2216227A1 Dna encoding galanin galr2 receptors and uses thereof |
| 07/30/1997 | EP0786523A2 Protein kinase and method of using |
| 07/30/1997 | EP0786522A2 Enzymatic RNA molecules for treatment of stenotic conditions |
| 07/30/1997 | EP0786521A1 Nucleic acid encoding PspA |
| 07/30/1997 | EP0786520A1 Method for the production of biological active beta-NGF by genetic engineering |
| 07/30/1997 | EP0786519A2 Staphylococcus aureus polynucleotides and sequences |
| 07/30/1997 | EP0786474A1 A recombinant buman factor VIII derivative |
| 07/30/1997 | EP0786472A1 Vaccines and diagnostic assays for Haemophilus influenzae |
| 07/30/1997 | EP0786469A2 Nucleic acid ligands |
| 07/30/1997 | EP0786257A1 Tissue plasminogen activator glycosylation variants with improved therapeutic properties |
| 07/30/1997 | EP0786256A2 Obesity protein formulations |
| 07/30/1997 | EP0786084A1 Method for screening compositions |
| 07/30/1997 | EP0786014A1 Massively parallel sequencing of sorted polynucleotides |
| 07/30/1997 | EP0786010A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins |
| 07/30/1997 | EP0786009A1 Process for bacterial production of heterologous polypeptides with disulphide bonds |
| 07/30/1997 | EP0786007A1 Transgenic nonhuman animal having functionally disrupted interleukin-1-beta converting enzyme gene |
| 07/30/1997 | EP0786006A2 Cephalosporin c amidohydrolase, production and use |
| 07/30/1997 | EP0786005A1 Method, reagent and kit for evaluating susceptibility to premature atherosclerosis and treatment of same using gene therapy |
| 07/30/1997 | EP0786004A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 07/30/1997 | EP0786003A1 Insect viruses and their uses in protecting plants |
| 07/30/1997 | EP0786002A1 Intracellular isoform of the interleukin-1 receptor antagonist |
| 07/30/1997 | EP0786001A1 Chemokine-like proteins and methods of use |
| 07/30/1997 | EP0786000A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
| 07/30/1997 | EP0785999A1 Plant transcription regulators from circovirus |
| 07/30/1997 | EP0785998A1 Asymmetric hammerhead ribozymes and nucleotide sequences for their construction |
| 07/30/1997 | EP0785997A2 Delivery system |
| 07/30/1997 | EP0785996A1 Nucleotide sequences and process for amplifying and detection of hepatitis b virus |
| 07/30/1997 | EP0785995A1 A novel enzyme with beta-1,3-glucanase activity |
| 07/30/1997 | EP0785994A1 An enzyme with lipolytic activity |
| 07/30/1997 | EP0785992A1 Conditional transformation of genetically engineered cells |
| 07/30/1997 | EP0785991A1 Preparation of rep-negative aav mutants and cells which can be used therefor |
| 07/30/1997 | EP0785988A1 Method of synthesizing saccharide compositions |
| 07/30/1997 | EP0785987A2 Flow through electroporation apparatus and method |
| 07/30/1997 | EP0785950A2 Keratinocyte growth factor analogs |
| 07/30/1997 | EP0785949A1 Method for purifying keratinocyte growth factors |
| 07/30/1997 | EP0785948A1 Analogs of keratinocyte growth factor |
| 07/30/1997 | EP0785946A1 Materials for the production of nanometer structures and use thereof |
| 07/30/1997 | EP0785942A1 Cationic oligonucleotides, and related methods of synthesis and use |
| 07/30/1997 | EP0785941A1 Porphyrin labeling of polynucleotides |
| 07/30/1997 | EP0785803A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 07/30/1997 | EP0785727A1 Preparation of frozen fermented foods using antifreeze polypeptide-expressing microorganisms |
| 07/30/1997 | EP0785716A1 Cytokine designated lerk-6 |
| 07/30/1997 | EP0703825B1 Method and apparatus for conducting an array of chemical reactions on a support surface |
| 07/30/1997 | EP0604495B1 Secondary-metabolite biosynthesis genes from actinomycetes, method of isolating them, and their use |
| 07/30/1997 | EP0505500B1 Endogenous gene expression modification with regulatory element by way of homologous recombination |
| 07/30/1997 | CN1155907A Transformation of guar |
| 07/30/1997 | CN1155906A Heat-stable prolylendopeptidase |
| 07/30/1997 | CN1155905A Crosslinked polyacrylamide gels with high monomer crosslinker ratios |
| 07/30/1997 | CN1155904A LAG-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 07/30/1997 | CN1155903A T cell antigen receptor V region proteins and methods of preparation thereof |
| 07/30/1997 | CN1155582A Converted gene cell line for expressing surface antigen of hepatitis Beffectively |
| 07/29/1997 | US5652356 Inverted chimeric and hybrid oligonucleotides |
| 07/29/1997 | US5652355 Hybrid oligonucleotide phosphorothioates |
| 07/29/1997 | US5652354 Stamen-selective promoters |
| 07/29/1997 | US5652353 DNAs encoding tumor necrosis factor-α muteins |
| 07/29/1997 | US5652352 Afamin: a human serum albumin-like gene |
| 07/29/1997 | US5652350 Complementary DNA and toxins |
| 07/29/1997 | US5652343 Method for purification of L-selectin ligands |
| 07/29/1997 | US5652340 Matrix-associating DNA-binding protein, nucleic acids encoding the same and methods for detecting the nucleic acids |
| 07/29/1997 | US5652338 Neutrophil chemotactic factor |
| 07/29/1997 | US5652333 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
| 07/29/1997 | US5652224 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 07/29/1997 | US5652223 DNA encoding CAI resistance proteins and uses thereof |
| 07/29/1997 | US5652222 Selective inhibition of leukemic cell proliferation by bcr-abl antisense oligonucleotides |
| 07/29/1997 | US5652217 Nucleotide sequence from staphylococcus aureus which codes for protein or polypeptide |
| 07/29/1997 | US5652210 Soluble splice variant of the Fas (APO-1) antigen, FasΔTM |
| 07/29/1997 | US5652144 YC1 gene |
| 07/29/1997 | US5652141 Device and process for isolating nucleic acids from cell suspension |
| 07/29/1997 | US5652139 DNA comprising lamb secretion signal sequence and mature IGF-1 sequence |
| 07/29/1997 | US5652138 Immunoreacts with human immunodeficiency virus glycoprotein |
| 07/29/1997 | US5652137 Bacillus isolated from citrus peel degrades limonene |
| 07/29/1997 | US5652136 Enzyme mutant where catalytic functionality has been modified or replaced, mutant will have preference for substrates supplying the modified or replaced catalytic functional group |
| 07/29/1997 | US5652133 Cloning and expression of the human macrophage inflammatory protein-1.alpha.α) /rantes receptor |
| 07/29/1997 | US5652132 Oxido reductase enzyme system obtainable from P. chrysogenum, the set of genes encoding the same and the use of oxido reductase enzyme systems or genes encoding the same for increasing antibiotic production |
| 07/29/1997 | US5652131 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods |
| 07/29/1997 | US5652130 Retroviral vectors expressing tumor necrosis factor (TNF) |
| 07/29/1997 | US5652128 Method for producing tagged genes, transcripts, and proteins |